Company Number: 13570834

Analysis Date: 2025-07-20 14:29 UTC

Comprehensive Financial Health Assessment for STORELAB LTD (as of 31 March 2024)

---

1. Financial Health Score: D

Explanation:
STORELAB LTD is currently exhibiting significant financial distress. The company’s balance sheet shows net liabilities deeply in negative territory, increasing sharply over the last year. Current liabilities far exceed current assets, indicating severe working capital issues and liquidity strain. Although the directors state going concern status, the financial "vital signs" suggest underlying distress symptoms requiring urgent attention.

---

2. Key Vital Signs (Core Metrics & Interpretation)

Metric	2024 Value	Interpretation
Net Assets (Shareholders’ Funds)	-£2,279,116	Strongly negative net worth; balance sheet "in shock"
Net Current Assets (Working Capital)	-£1,336,157	Acute liquidity deficiency; immediate cash flow risk
Fixed Assets (Intangible + Tangible)	£352,565	Investment in app/software development; long-term assets healthy
Cash on Hand	£21,527	Low cash reserves relative to liabilities; “weak pulse”
Total Current Liabilities	£1,443,566	Very high short-term debts; “high blood pressure” on finances
Long-Term Liabilities	£1,295,524	Substantial long-term debt raising solvency concerns
Debtors (Receivables)	£85,882	Moderate; some cash expected but insufficient for immediate needs
Share Capital	£40	Nominal share capital; limited equity buffer

Additional Observations:

• Rapid deterioration: Net assets dropped from -£311k (2023) to -£2.28m (2024), a red flag for financial health.
• Loans from related parties amounting to over £900k and £35k indicate reliance on shareholder/director funding to keep the company afloat.
• Amortised intangible assets at £337k represent capitalised development costs, which may not be readily liquidated.
• Increased lease commitments suggest fixed overhead costs rising, adding pressure to cash flow.

---

3. Diagnosis: What the Financial Data Reveals

STORELAB LTD is showing symptoms of financial distress with an alarming liquidity crunch and balance sheet insolvency:

• Liquidity Crisis: Negative net current assets indicate the company cannot cover its short-term debts with its available current assets. This is akin to a patient with a dangerously low blood pressure—cash reserves are insufficient to meet immediate obligations.

• Balance Sheet Insolvency: The net liabilities position indicates the company’s obligations exceed its total assets by a large margin. This is a chronic symptom of “organ failure” financially, where the company’s net worth is deeply negative.

• Heavy Reliance on Related Party Loans: The company depends heavily on shareholder/director loans, which suggests external financing sources (banks, investors) may be limited or exhausted.

• Growth Investment vs. Financial Health: The company is investing in intangible assets (app development), which is positive for future revenue streams. However, this growth investment is currently overshadowed by severe financial strain.

• Going Concern Note: Directors’ assertion that the company is a going concern is dependent on continued shareholder support. Without this, the prognosis would be critical.

---

4. Prognosis: Future Financial Outlook

• Short-Term Outlook: High risk of operational disruption due to cash flow constraints. Without immediate liquidity improvement, the company faces potential insolvency or forced restructuring.

• Medium to Long-Term: If the company can stabilise cash flow, reduce liabilities, and convert intangible investments into profitable revenue streams, recovery is possible. However, the current financial "patient" is in fragile condition and requires intensive care.

---

5. Recommendations: Specific Actions to Improve Financial Wellness

• Urgent Cash Flow Management:

  • Negotiate extended payment terms with creditors to ease short-term pressures.
  • Accelerate collection of receivables.
  • Review and reduce discretionary expenses and overheads immediately.

• Capital Structure Restructuring:

  • Explore equity injection to improve net asset position and strengthen balance sheet.
  • Consider refinancing or restructuring existing debt to reduce interest burdens and extend maturities.

• Operational Efficiency:

  • Conduct detailed cost-benefit analysis of intangible asset investments to ensure future value generation.
  • Implement tighter budget controls and financial forecasting to monitor "vital signs" regularly.

• Stakeholder Communication:

  • Transparently communicate with shareholders and lenders regarding financial status and recovery plans.
  • Seek professional advice on insolvency prevention measures if liquidity does not improve.

• Strategic Review:

  • Evaluate business model sustainability in light of financial stress.
  • Explore partnerships or mergers to bolster financial and operational strength.

---

Medical Analogy Summary

STORELAB LTD currently exhibits symptoms of acute financial distress: a dangerously low cash "pulse," severe "organ" (balance sheet) failure, and dependency on "life support" from shareholder loans. Immediate intervention is critical to stabilize the company’s financial health and prevent collapse.

---